Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peptide Vaccine for Bladder Cancer Recurrence Prevention
NCT00633204Phase 2Unknown
- Sponsor
- Iwate Medical University
- Start
- Feb 2008
- Primary completion
- Nov 2011
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of DEPDC1-9-294, MPHOSPH1-9-278 in bladder cancer, sponsored by Iwate Medical University. Status: unknown.
02
Drugs
DEPDC1-9-294MPHOSPH1-9-278
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00633204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633204.